We compared the analytical and clinical performance of two free-thyroxine (FT4) assays-a solid-phase radioimmunoassay, Spectria, and a time-resolved fluoroimmunoassay, Delfia, both of them two-step methods-with the performance of a direct radioimmunoassay, Nichols, to measure FT4 concentration in equilibrium dialysate of undiluted serum. function (3,4) . Until recently, the reference method for FF1, equilibrium dialysis of undiluted serum followed by measurement of T4 in the dialysate, was unsuitable for routine use (5, 6). Alternative techniques developed over the past 10 years have generated more discussion and controversy than solutions for everyday laboratory practice (7, 8).
the influenceof temperature on performance and calibration. Most important was the neglected fact that the association constant for the binding of thyroxine to thyroxine-binding globulin decreases when the temperature rises from 20 to 37#{176}C, causing a doubling of FT4. The two-step assays, if performed at room temperaturewithout a well-defined calibration, can give misleading FT4 concentrations. This is the case when sera from patients with thyroxine-bindingabnormalities are measured against kit standards, made up in normal humansera. If 
MaterIals and Methods

Subjects
The clinical performance of the assays was studied in sera from 196 subjects in the following groups: (a) 66 
Samples and Control Sera
Serum pools containing low (I, A) and normal (II, B) concentrations of FT4 were prepared from serum samples not being tested for thyroid-associated hormones. Serum pools (UI, C) containing a high concentration of F!4 were prepared by adding L-thyroxine Table 1 shows the principal characteristics of the kits. All assays were performed according to the protocols of their manufacturers, except for the temperature studies, in which the following modifications were introduced: In the Nichols assay the serum was dialyzed for 7 days at room temperature instead of at 37#{176}C. (A pilot experiment showed that dialysis did not reach equilibrium at room temperature in <7 days.) In the Delfia and the Spectria assays the first incubation step was performed at 37#{176}C instead of at room temperature for standards and samples. The remaining part of the procedure was done according to the manufacturers' instructions.
To get an impression of matrix effects, we diluted the serum with an inert aqueous diluent (7). The experi menta were carried out with HEPES-buffer All measurements were carried out in duplicate.
Results
Analytical Evaluation
Sensitivity (lower detection limit). The lower detectioi limit was determined by replicate analysis (n = 10) o the zero standard. It was defined as the FT4 concentra tion corresponding to the response of the mean and 2S1 response of the zero standard. We found 1.4, 1.4, and O.
11.1 10.1 9.6 8 10 Because we were unable to prepare a T4-free serum that was charcoal-free as well, dilutions with serum matrix could not be performed.
Effect of temperature. Three serum pools and patient sera from different groups were measured at room temperature and at 37#{176}C, by the Nichols, Spectria, and Delfia assays (Table 3) . The results obtained with the Nichols assay were strongly temperature dependent, reflecting the theoretical factor of -2. The temperature dependence was significantly smaller when the Delfia or Spectria assays were used, except for the TBG-deficient group.
Clinical Evaluation
The clinical performance of the three assays was investigated in sera from 205 subjects, classified according to the clinical diagnosis. The findings were compared with the expected (reference) values given by the manufacturers (Table 1) . Euthyroid control subjects. In 66 euthyroid control subjects, VP4 concentrations (mean ± SD) of 14.5 ± 2.9, 10.7 ± 2.1, and 8.6 ± 1.7 pmol/L and 95% reference intervals of 9.3-19.4, 7.2-14.3, and 5.6-11.8 pmol/L were found by using the Nichols, Delfia, and Spectria kits, respectively. All these values were lower than the reference concentrations (Table 1) . Accordingly, sera from 3 euthyroid subjects with Nichols, 5 with Delfia, and 11 with Spectria assays showed lower Fr4 concentrations than did the reference concentrations given by the manufacturers (Figure 3) 3 with the Nichols, 4 with the Delfia, and 9 with the Spectria assays.
Patients with nonthyroidal illness. In sera from the group of 6 NT! patients with a low 1TT4,3 patients showed low Fr4: 2 in the Spectria and Delfia assays; and only 1 patient in the Spectria assay.
Patients with thyroid illness. Sera from 6 hyperthyroid patients had normal Fr4 concentrations as measured with the Nichols kit, and 3 were normal when measured with the Delfin kit. All the results obtained with the Spectria kit in sera from hyperthyroid patients were above the reference concentrations. All Fr4 results in sera from hypothyroid patients with the three kits were below the reference concentrations.
DIscussion
The analytical data for the three assays show no basi differences in sensitivity, precision, or working range One could expect that dilution over a large range doe not affect the Fr4 concentration (5) (6) (7) . Therefore, dilu tion experiments can give an impression of the matri effects involved. The three assays tested showed devia tions; the Nichols kit was the least sensitive for dilutioi effects (Figure 2 ). In our opinion, however, there is n reason to reject one of these assays on the basis of th analytical evaluation. We find it interesting that thei is a discrepancy between the reference concentratior we found and those reported by the different manufa turers. Moreover, significant differences were found & tween the assays for the Fr4 concentrations measure in sera from the same euthyroid subjects. This led us t have a closer look at standardization, in particular a the influence of temperature, which proved essential.
It is known from the literature (12) that the associa tion constant for the binding of T4 to TBG is strongi temperature dependent. It can be calculated from thea published data that the free fraction of T4 increases by factor of -2 when the temperature rises from 20 t 37#{176}C. Indeed, this effect has been observed (13), but it remarkable that the findings and their consequences for standardization were not discussed by the authors. Nevertheless, temperature dependence could explain the differences observed in sera from euthyroid subjects and the discrepancy in the expected concentrations given by the manufacturers (Table 1) ; the Nichols assay was performed at 37#{176}C, and the Delfia and Spectria assays were done at room temperature.
To check this hypothesis we first performed the Nichols assay at room temperature and at 37#{176}C (Table  3) . We found the expected factor of -2 for the measured Fr4 concentrations.
It is important that the standards of the Nichols kit do not contain TBG or other binding proteins. This is in contrast to the standards of the Delfia and Spectria kits, which are made up in human serum. found at different temperatures to show larger differences than the normal control subjects do. Indeed, this seems to be the case with the Delfia assay (Table 3) .
In an absolute sense, the concentrations depend of course on the Fr4 concentration the manufacturer assigns to the standards.
It is symptomatic that the leaflets in the Delfia and Spectria kits state that the standards are calibrated by a dialysis method, although no reference is made to the temperature at which the dialysis was performed.
This is a remarkable shorthorning. It is surprising that the very important aspects of the temperature in calibration and performance of Fr4 assays are, as far as we know, never discussed in the literature about this subject. 
